Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KPTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PMEPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC11A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00858 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C17orf50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IP6K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNPY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBOAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFNA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF816-ZNF321P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on